Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Pfizer puts $500m into gene therapy, expands manufacturing facility

Pfizer invests half a billion dollars to expand its gene therapy manufacturing facility in North Carolina and enhance its position to compete in the booming market.

US funds additional year of Ebola vaccine manufacture

The US HSS will provide funding to Merck for a year’s supply of its investigational Ebola vaccine for use in DR Congo to combat the repeated outbreaks of the virus.

Packager limits intra-facility travel to address ‘critical out-of-cold-storage time’

Contract packaging provider Reed-Lane adds dedicated room for vial and ampule kitting to its cold chain capabilities to limit intra-facility travel and product excursion as a means of security.

WuXi Biologics posts global growth despite ‘geopolitical uncertainties’

In 1H financials, WuXi Biologics outlines positive developments across its ‘three major markets’, stressing that US growth is still strong despite US-China trade relations.

Supply chain to supply ‘cycle’: TrakCel CEO talks cell and gene therapies tracking

The increasing number of cell and gene therapies in clinical development is evolving the supply chain into a ‘supply cycle,’ says TrakCel CEO, with service providers being called to maintain control under pressure.